Today’s top gainers include the company Novo Nordisk A/S (NYSE:NVO) which is in the industry Drug Manufacturers – Other, gaining 0.87% today. In the last week its performance is 3.04%, and -5.38% for the past quarter. Currently, Novo Nordisk A/S, NVO has a target price of 60.1, so today’s gain of 0.87% is a significant step towards its target price. The GAP today is therefore 0.46%.
Novo Nordisk A/S (NYSE:NVO), has a market cap of 106903.2, and is based in Denmark. Insider ownership is at 26.40%, and institutional ownership is 10.20%.
At the current price of 54.29, it has a dividend yield of 1.78%, and its target price is 60.1. This is with a profit margin of 31.30%, and total debt/equity of 0.01. Novo Nordisk A/S (NYSE:NVO) has a P/E of 26.83, as well as a forward P/E of 21.59.
With a current EPS of 2.01, and a forecasted EPS growth for next year at 8.39%,Novo Nordisk A/S (NYSE:NVO) has had a EPS growth for the past five years at 22.40%. For the next five years EPS growth is projected to be 11.70%.
Performance for the year is 0.91%. Since its IPO date on 01/04/1982, the total performance to date is -5.69%.
Volume today for Novo Nordisk A/S (NYSE:NVO), is 451382, while its average volume is 1353.79. Whilst the total gain today was 0.87%, it did have a day high of -5.48%.
Volatility for this week has been at 1.42%, and 1.51% for the month. The 52-week low for Novo Nordisk A/S, NVO has been 19.67%, while the 52-week-high has reached -8.43%.
Looking at its return of investments, which is 85.00%, and its return on assets is 40.40%. Novo Nordisk A/S (NYSE:NVO) has an operating margin of 43.60%. With a sales growth of 8.00% quarter over quarter. Bearing in mind that Novo Nordisk A/S, NVO is in the sector Healthcare, its long-term debt/equity is 0, and has a current ratio of 1.1 and 0.8 for quick ratio.
So what is the value of Novo Nordisk A/S? Well its PEG is 2.29, and the P/S is 6.51, along with a P/B of 24.58. Meanwhile it has a p/cash of 80.88.